Author

Stephanie Lanier

Institution: Mayo Clinic in Florida

Observed institutions: Mayo Clinic, Mayo Clinic in Florida

OpenAlex ID: A5049145294

AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma

2023 · Sikander Ailawadhi, Ricardo D. Parrondo, et al. · Cancers · 6

Phase I Study of a Novel Bcl-2 Inhibitor, at-101 in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

2019 · Sikander Ailawadhi, Victoria R. Alegria, et al. · Blood · 4

Peri-Transplant and Maintenance Daratumumab for Minimal Residual Disease (MRD) Eradication in Transplant-Eligible Multiple Myeloma (MM) Patients

2022 · Sikander Ailawadhi, Ricardo D Parrondo, et al. · Blood · 2

Works count: 3

Citation count: 12

H-index: 2

I10-index: